Stock listing
CSE:IZO Izotropic Corp. Stock
Home listing (CSE) of Izotropic Corp.
Follow Izotropic Corp. into a list and get an email when it puts out news.
Share price · CSE:IZO
$0.125 CAD +0.020 (+19.0%)
Close on Nov 20, 2026
- Day range
- $0.125 – $0.125 CADNov 20, 2026
- Volume
- 6,455 sharesNov 20, 2026
- Market cap
- $9.04M CADAt the close on Nov 20, 2026 · price × 72.32M shares outstanding
- 52-week range
- $0.100 – $0.360 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $3,668 CADMedian day 9,600 shares · 14 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:IZO · Home | $0.125 CAD | +0.020 (+19.0%) | 6,455 | $0.125 | $0.125 | $0.125 | $0.105 | Close on Nov 20, 2026 |
| OTC:IZOZF | $0.084 USD | -0.006 (-6.3%) | 7,244 | $0.084 | $0.084 | $0.084 | $0.090 | Close on Nov 20, 2026 |
| Frankfurt:1R3 | €0.057 EUR | +0.002 (+3.7%) | — | €0.057 | €0.057 | €0.057 | €0.055 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · CSE:IZO · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.125 | +0.020 | +19.0% | $0.125 | $0.125 | $0.125 | 6,455 | |
| $0.105 | -0.020 | -16.0% | $0.105 | $0.110 | $0.105 | 4,000 | |
| $0.125 | 0.000 | 0.0% | $0.125 | $0.125 | $0.125 | 0 | |
| $0.125 | 0.000 | 0.0% | $0.125 | $0.125 | $0.125 | 0 | |
| $0.125 | 0.000 | 0.0% | $0.125 | $0.125 | $0.125 | 0 | |
| $0.125 | 0.000 | 0.0% | $0.125 | $0.125 | $0.125 | 23,787 | |
| $0.125 | 0.000 | 0.0% | $0.125 | $0.125 | $0.125 | 0 | |
| $0.125 | 0.000 | 0.0% | $0.125 | $0.125 | $0.125 | 0 | |
| $0.125 | 0.000 | 0.0% | $0.125 | $0.125 | $0.120 | 21,070 | |
| $0.125 | +0.010 | +8.7% | $0.125 | $0.125 | $0.125 | 3,566 | |
| $0.115 | +0.015 | +15.0% | $0.125 | $0.135 | $0.115 | 8,485 | |
| $0.100 | -0.010 | -9.1% | $0.110 | $0.125 | $0.100 | 96,652 | |
| $0.110 | -0.025 | -18.5% | $0.130 | $0.140 | $0.100 | 164,050 | |
| $0.135 | 0.000 | 0.0% | $0.135 | $0.135 | $0.135 | 22,000 | |
| $0.135 | -0.005 | -3.6% | $0.140 | $0.140 | $0.135 | 11,014 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 0 | |
| $0.140 | -0.005 | -3.4% | $0.150 | $0.150 | $0.140 | 6,000 | |
| $0.145 | 0.000 | 0.0% | $0.145 | $0.145 | $0.145 | 0 | |
| $0.145 | +0.005 | +3.6% | $0.145 | $0.145 | $0.145 | 4,530 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 0 | |
| $0.140 | -0.020 | -12.5% | $0.145 | $0.145 | $0.140 | 22,000 | |
| $0.160 | +0.005 | +3.2% | $0.155 | $0.160 | $0.155 | 38,920 | |
| $0.155 | 0.000 | 0.0% | $0.155 | $0.155 | $0.150 | 34,000 | |
| $0.155 | +0.005 | +3.3% | $0.160 | $0.160 | $0.150 | 103,501 | |
| $0.150 | 0.000 | 0.0% | $0.150 | $0.150 | $0.150 | 0 | |
| $0.150 | -0.010 | -6.3% | $0.160 | $0.160 | $0.150 | 44,500 | |
| $0.160 | 0.000 | 0.0% | $0.150 | $0.160 | $0.150 | 26,490 | |
| $0.160 | -0.020 | -11.1% | $0.165 | $0.165 | $0.150 | 63,096 | |
| $0.180 | +0.010 | +5.9% | $0.180 | $0.180 | $0.180 | 10,000 | |
| $0.170 | +0.030 | +21.4% | $0.170 | $0.170 | $0.170 | 1,971 | |
| $0.140 | -0.040 | -22.2% | $0.165 | $0.165 | $0.140 | 65,200 | |
| $0.180 | +0.015 | +9.1% | $0.175 | $0.180 | $0.175 | 11,000 | |
| $0.165 | -0.005 | -2.9% | $0.190 | $0.190 | $0.165 | 18,000 | |
| $0.170 | -0.025 | -12.8% | $0.190 | $0.190 | $0.170 | 9,600 | |
| $0.195 | 0.000 | 0.0% | $0.195 | $0.195 | $0.195 | 0 | |
| $0.195 | -0.005 | -2.5% | $0.195 | $0.195 | $0.190 | 64,000 | |
| $0.200 | +0.005 | +2.6% | $0.200 | $0.205 | $0.195 | 69,000 | |
| $0.195 | -0.005 | -2.5% | $0.200 | $0.200 | $0.195 | 6,800 | |
| $0.200 | +0.010 | +5.3% | $0.195 | $0.205 | $0.195 | 17,750 | |
| $0.190 | -0.010 | -5.0% | $0.280 | $0.280 | $0.175 | 129,086 | |
| $0.200 | -0.010 | -4.8% | $0.225 | $0.225 | $0.200 | 2,501 | |
| $0.210 | +0.020 | +10.5% | $0.210 | $0.210 | $0.210 | 800 | |
| $0.190 | 0.000 | 0.0% | $0.190 | $0.190 | $0.190 | 0 | |
| $0.190 | -0.035 | -15.6% | $0.200 | $0.215 | $0.190 | 26,349 | |
| $0.225 | +0.035 | +18.4% | $0.225 | $0.225 | $0.225 | 5,000 | |
| $0.190 | -0.010 | -5.0% | $0.190 | $0.190 | $0.190 | 7,505 | |
| $0.200 | -0.010 | -4.8% | $0.190 | $0.210 | $0.190 | 27,595 | |
| $0.210 | 0.000 | 0.0% | $0.210 | $0.210 | $0.190 | 34,360 | |
| $0.210 | -0.005 | -2.3% | $0.210 | $0.210 | $0.210 | 1,250 | |
| $0.215 | 0.000 | 0.0% | $0.225 | $0.225 | $0.215 | 14,887 | |
| $0.215 | -0.005 | -2.3% | $0.225 | $0.225 | $0.215 | 24,500 | |
| $0.220 | -0.015 | -6.4% | $0.220 | $0.225 | $0.215 | 26,972 | |
| $0.235 | 0.000 | 0.0% | $0.235 | $0.235 | $0.235 | 0 | |
| $0.235 | 0.000 | 0.0% | $0.215 | $0.235 | $0.215 | 33,000 | |
| $0.235 | +0.020 | +9.3% | $0.215 | $0.235 | $0.215 | 15,017 | |
| $0.215 | 0.000 | 0.0% | $0.235 | $0.235 | $0.215 | 5,704 | |
| $0.215 | -0.020 | -8.5% | $0.225 | $0.225 | $0.215 | 11,650 | |
| $0.235 | -0.005 | -2.1% | $0.235 | $0.235 | $0.230 | 51,150 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | +0.010 | +4.3% | $0.230 | $0.240 | $0.230 | 17,750 | |
| $0.230 | 0.000 | 0.0% | $0.235 | $0.235 | $0.230 | 9,000 | |
| $0.230 | -0.005 | -2.1% | $0.220 | $0.230 | $0.220 | 4,500 | |
| $0.235 | -0.010 | -4.1% | $0.235 | $0.235 | $0.235 | 2,000 | |
| $0.245 | 0.000 | 0.0% | $0.245 | $0.245 | $0.245 | 0 | |
| $0.245 | 0.000 | 0.0% | $0.245 | $0.245 | $0.245 | 3,500 |
- Ticker
- CSE:IZO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- CSE
- Currency
- CAD
What changed lately
Latest news release · Oct 6, 2026
Izotropic Closes Non-Brokered Private Placement
Latest deck · 2026
Investor Presentation (2026)
Investor deck · 15 slides
Latest news
Izotropic Closes Non-Brokered Private Placement
Oct 6, 2026
Closed $0.165 (-2.9%) on Oct 6, 2026
Izotropic Announces Non-Brokered Private Placement
Sep 25, 2026
Closed $0.19 (-5.0%) on Sep 25, 2026
8/10/2026 Izotropic Grants RSUs to Consultants
Aug 10, 2026
Closed $0.25 (+2.0%) on Aug 10, 2026
Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC
Jul 2, 2026
Closed $0.28 (+16.7%) on Jul 2, 2026
Izotropic Africa Launches Operations in Casablanca
Apr 29, 2026
Closed $0.315 (-4.5%) on Apr 29, 2026
Izotropic Announces Debt Settlement
Apr 21, 2026
Closed $0.27 (+8.0%) on Apr 21, 2026
Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health
Feb 25, 2026
Closed $0.235 (+2.2%) on Feb 25, 2026
Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC
Feb 18, 2026
Closed $0.245 (+22.5%) on Feb 18, 2026
Izotropic Closes Non-Brokered Private Placement and Announces Debt Settlement
Feb 4, 2026
Closed $0.235 (+2.2%) on Feb 4, 2026
Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement
Jan 28, 2026
Closed $0.25 (+8.7%) on Jan 28, 2026
Izotropic Corp. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 11 in the last 12 months · 38 in all · newest Oct 6, 2026 · oldest 2025
- Decks
- 18 decks · latest 2026
Where Izotropic Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:IZO · Home listing · This page | CSE | Canada | CAD |
| OTC:IZOZF | OTC | United States | USD |
| gettex:1R3 | gettex | Germany | EUR |
| LS Exchange:A2JNLV | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2JNLV | Lang & Schwarz | Germany | EUR |
| Tradegate:1R3 | Tradegate | Germany | EUR |
| Frankfurt:1R3 | Frankfurt | Germany | EUR |
| Munich:1R3 | Munich | Germany | EUR |
| Cboe Canada:IZO | Cboe Canada | Canada | CAD |
| Stuttgart:1R3 | Stuttgart | Germany | EUR |
Valuation
Statements: 4 quarters to Jul 31, 2026 · price Nov 20, 2026
- Enterprise value
- $8.98M CAD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P/TSX Composite
- 0.21
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Izotropic Corp. · CSE:IZO | US$6.30M | US$6.26M | n/a | n/a | n/a | n/a | n/a | n/a | 0.21 |
| Clinical Laserthermia Systems AB Class B · OMXSTO:CLS_B | US$7.54M | US$7.17M | n/a | 5.8× | n/a | 1.6× | −314.6% | 0.0× | n/a |
| BioElectronics Corp. · OTC:BIEL | US$7.41M | US$23.70M | n/a | 46.4× | n/a | n/a | −104.3% | n/a | 2.45 |
| Airway Medix SA · GPW:AWM | US$6.73M | US$10.07M | n/a | 278× | n/a | n/a | n/a | n/a | n/a |
| Surgical Innovations Group plc · LSE:SUN | US$6.71M | US$7.01M | n/a | 0.5× | n/a | 0.7× | −7.7% | 0.1× | n/a |
| Accuray Incorporated · NASDAQ:ARAY | US$6.20M | US$65.61M | n/a | 0.2× | n/a | 0.1× | −4.4% | 1.9× | 2.46 |
| NeuroOne Medical Technologies Corporation · NASDAQ:NMTC | US$5.94M | US$3.89M | n/a | 0.4× | n/a | 1.6× | −78.6% | 0.0× | 1.07 |
| Neola Medical AB · OMXSTO:NEOLA | US$5.46M | US$5.07M | n/a | n/a | n/a | 0.6× | n/a | 0.0× | n/a |
| ENDRA Life Sciences Inc. · NASDAQ:NDRA | US$5.36M | US$3.85M | n/a | n/a | n/a | 1.0× | n/a | 0.0× | 1.07 |
| MEKICS Co., Ltd. · KRX:058110 | US$5.23M | US$2.04M | 6.6× | 0.2× | 1.3× | 0.2× | 7.7% | 0.1× | n/a |
| PT Hetzer Medical Indonesia Tbk · IDX:MEDS | US$5.16M | US$5.45M | n/a | n/a | n/a | 1.8× | n/a | 0.1× | n/a |
| Median of the others | US$6.07M | US$6.23M | 6.6× | 0.5× | 1.3× | 0.9× | −43.2% | 0.0× | 1.76 |
Forecasts
Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 1.16 CAD · Analysts' mean
- Revenue, year to Apr 2027
- 5M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Robert Thast | CEO, Director |
| Ralph Proceviat | CPA, CFO, Director |
| Andrew Hernandez | Ph.D., Head of Imaging Technology |
| Jaclyn Thast | Operations Manager |
| John Boone | Ph.D., Principal Founder of Breast CT, Director |
| Mohammed Sair | General Manager |
Board
| Director | Role |
|---|---|
| Alexander Tokman | Director |
| Ali Sodagar | Legal Advisor, Director |
| John Boone | Ph.D., Principal Founder of Breast CT, Director |
| Ralph Proceviat | CPA, CFO, Director |
| Robert Thast | CEO, Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (2026) | Investor deck | 15 slides | 2026 |
| Investor Presentation (2026) | Investor deck | 12 slides | 2026 |
| Investor Presentation (August 2025) | Investor deck | 12 slides | August 2025 |
| Fact Sheet (August 2025) | Fact sheet | 2 slides | August 2025 |
| Investor Presentation (March 2024) | Investor deck | 13 slides | March 2024 |
| Fact Sheet (January 2023) | Fact sheet | 2 slides | January 2023 |
| Investor Presentation (December 2022) | Investor deck | 26 slides | December 2022 |
| Investor Presentation (September 2022) | Investor deck | 26 slides | September 2022 |
| Investor Presentation (May 2022) | Investor deck | 26 slides | May 2022 |
| Investor Presentation (April 2022) | Investor deck | 28 slides | April 2022 |
All 18 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2021) | Investor deck | 28 slides | December 2021 |
| Investor Presentation (October 2021) | Investor deck | 22 slides | October 2021 |
| Investor Presentation (April 2021) | Investor deck | 20 slides | April 2021 |
| Investor Presentation (March 2021) | Investor deck | 20 slides | Mar 22, 2021 |
| Fact Sheet (December 2020) | Fact sheet | 1 slide | December 2020 |
| Fact Sheet (September 2020) | Fact sheet | 1 slide | September 2020 |
| Fact Sheet (June 2020) | Fact sheet | 1 slide | June 2020 |
| Investor Presentation | Investor deck | 11 slides |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of units Closed: C$150,000 raised · C$0.2 a unit · 1 warrant at C$0.3 for 36 months Use of proceeds: General working capital | Oct 6, 2026 | US$105,441 |
| Private placement of units Closed: C$300,000 raised · C$0.25 a unit · 1 warrant at C$0.25 for 36 months Use of proceeds: General working capital | Feb 4, 2026 | US$219,491 |
| Private placement of units Closed: C$375,000 raised · C$0.25 a unit · 1 warrant at C$0.5 for 36 months Insiders: An insider of the Company acquired 100,000 Units Use of proceeds: General working capital | Sep 19, 2025 | US$271,976 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CAD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 33.9K | 0 | ||||||||
| Gross profit | -33.9K | 0 | ||||||||
| Research and development | 723.2K | 681.2K | 795.2K | 2.39M | 3.41M | 793.0K | 0 | |||
| Selling, general and administrative | 540.4K | 1.35M | 703.8K | 2.74M | 3.16M | 3.90M | 1.09M | 392.0K | 560.4K | 79.3K |
| Operating income | -1.44M | -2.22M | -1.70M | -5.33M | -6.64M | -4.98M | -1.16M | -398.5K | -598.9K | -79.3K |
| Depreciation and amortization | 33.4K | 48.9K | 59.1K | 30.9K | 6.87K | 1.63K | 3.28K | 6.54K | 4.54K | 4.54K |
| EBITDA | -1.41M | -2.17M | -1.64M | -5.30M | -6.63M | -4.97M | -1.15M | -392.0K | -594.4K | -74.8K |
| Interest expense | 478.5K | 286.1K | 253.1K | 294.4K | 19.5K | 0 | 0 | 0 | 0 | 0 |
| Income before tax | -2.18M | -3.14M | -1.56M | -5.66M | -6.65M | -4.98M | -1.16M | -398.5K | -730.1K | -107.3K |
| Income tax | 0 | 0 | ||||||||
| Net income | -2.18M | -3.14M | -1.56M | -5.66M | -6.65M | -4.98M | -1.16M | -398.5K | -730.1K | -107.3K |
| Earnings per share, basic | -0.03 | -0.05 | -0.03 | -0.11 | -0.15 | -0.12 | -0.04 | -0.02 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 219.7K | 274.1K | 38.6K | 165.7K | 1.86M | 4.06M | 613.6K | 308.5K | 471.9K | 149.4K |
| Receivables | 13.4K | 41.3K | 43.9K | 47.2K | 12.3K | 6.50K | 247 | |||
| Current assets | 330.4K | 395.7K | 166.2K | 317.3K | 2.25M | 4.69M | 774.0K | 332.5K | 478.6K | 149.7K |
| Property, plant and equipment | 124.8K | 19.0K | 1.63K | 3.26K | 6.54K | 13.1K | ||||
| Total assets | 439.8K | 414.7K | 232.4K | 442.1K | 2.27M | 4.69M | 777.2K | 339.1K | 491.6K | 149.7K |
| Accounts payable | 2.89M | 2.45M | 1.79M | 1.15M | 378.0K | 94.7K | 61.5K | 10.2K | 69.9K | 15.8K |
| Current liabilities | 5.99M | 5.27M | 4.06M | 3.46M | 2.64M | 169.3K | 70.0K | 22.2K | 83.9K | 214.4K |
| Total liabilities | 6.06M | 5.27M | 4.08M | 3.52M | 2.64M | 169.3K | 70.0K | 22.2K | 83.9K | 214.4K |
| Shareholders' equity | -5.63M | -4.86M | -3.85M | -3.07M | -374.6K | 4.52M | 707.2K | 316.8K | 407.8K | -64.7K |
| Shares outstanding | 69.7M | 64.4M | 55.0M | 51.9M | 44.8M | 42.0M | 30.0M | 23.2M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -851.3K | -636.2K | -593.6K | -3.27M | -4.76M | -3.08M | -987.4K | -442.6K | -604.9K | -55.2K |
| Capital spending | 0 | -1.14K | 0 | -36.2K | -24.2K | -24.2K | -24.2K | -24.2K | -17.6K | -17.6K |
| Free cash flow | -851.3K | -637.4K | -593.6K | -3.30M | -4.79M | -3.08M | -987.4K | -442.6K | -622.5K | -72.8K |
| Cash from investing | -36.2K | -24.2K | -24.2K | -24.2K | -24.2K | -17.6K | -17.6K | |||
| Cash from financing | 793.6K | 872.8K | 468.2K | 1.61M | 2.58M | 6.53M | 1.29M | 279.2K | 945.0K | 218.2K |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | |||||
| Change in cash | -54.4K | 235.5K | -127.1K | -1.69M | -2.21M | 3.45M | 305.1K | -163.4K | 322.5K | 163.0K |
Cap table
Built by 6ix from Izotropic Corp.’s releases · as of Oct 6, 2026
- Common shares
- 72,324,679
- Fully diluted
- 73,074,679
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 72,324,679 | Oct 6, 2026 |
| Options and RSUs | 750,000 | Aug 10, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · C$0.30 · expire about Oct 2029 |
| Warrants · C$0.25 · expire about Feb 2029 |
| Warrants · C$0.50 · expire about Sep 2028 |
| RSUs · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 72,324,679 |
| Oct 6, 2026 | 70,474,679 |
| Jul 31, 2026 | 69,724,679 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alexander Tokman | Director · Since at least Nov 5, 2026 |
| Ali Sodagar | Legal Advisor, Director · Since at least Nov 5, 2026 |
| Andrew Hernandez | Ph.D., Head of Imaging Technology · Since at least Nov 5, 2026 |
| Jaclyn Thast | Operations Manager · Since at least Nov 5, 2026 |
| John Boone | Ph.D., Principal Founder of Breast CT, Director · Since at least Mar 25, 2025 |
| John M. Viglotti | SVP Corporate Services · Mar 10, 2025 – Nov 4, 2026 · Past |
| Mohammed Sair | General Manager · Since at least Apr 29, 2026 |
| Ralph Proceviat | CPA, CFO, Director · Since at least Nov 5, 2026 |
| Robert Thast | CEO, Director · Since at least Oct 6, 2026 |
Log in to ask 6ix AI your own questions about Izotropic Corp.